MedTrace Logo

Feasibility Study of NL-Prow Interspinous Spacer to Treat Lumbar Spinal Stenosis

NCT01053364 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2011-01-05

No results posted yet for this study

Summary

The purpose of the study is to evaluate the clinical safety and feasibility of the NL-Prow™ Interspinous Spacer implant and insertion procedure in the treatment of lumbar spinal stenosis

Conditions

  • Lumbar Spinal Stenosis

Interventions

DEVICE

NL-Prow interspinous spacer implant

Interspinous spacer implant

Sponsors & Collaborators

  • Non-Linear Technologies

    lead INDUSTRY

Principal Investigators

  • Zdenek Novak, MD, PhD · St. Anne's University Hospital Brno, Czech Republic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053364 on ClinicalTrials.gov